• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

MRI 显示的卵巢癌与其他盆腔疾病的关系

Manifestations of Ovarian Cancer in Relation to Other Pelvic Diseases by MRI.

作者信息

Bourgioti Charis, Konidari Marianna, Moulopoulos Lia Angela

机构信息

Department of Radiology, School of Medicine, National and Kapodistrian University of Athens, Aretaieion Hospital, 76 Vas. Sofias Ave., 11528 Athens, Greece.

出版信息

Cancers (Basel). 2023 Mar 31;15(7):2106. doi: 10.3390/cancers15072106.

DOI:10.3390/cancers15072106
PMID:37046767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10093428/
Abstract

Imaging plays a pivotal role in the diagnostic approach of women with suspected ovarian cancer. MRI is widely used for preoperative characterization and risk stratification of adnexal masses. While epithelial ovarian cancer (EOC) has typical findings on MRI; there are several benign and malignant pelvic conditions that may mimic its appearance on imaging. Knowledge of the origin and imaging characteristics of a pelvic mass will help radiologists diagnose ovarian cancer promptly and accurately. Finally, in special subgroups, including adolescents and gravid population, the prevalence of various ovarian tumors differs from that of the general population and there are conditions which uniquely manifest during these periods of life.

摘要

影像学在疑似卵巢癌女性的诊断方法中起着关键作用。磁共振成像（MRI）广泛用于附件包块的术前特征描述和风险分层。虽然上皮性卵巢癌（EOC）在MRI上有典型表现，但有几种盆腔良恶性疾病在影像学上可能与其表现相似。了解盆腔包块的起源和影像学特征将有助于放射科医生及时、准确地诊断卵巢癌。最后，在特殊亚组中，包括青少年和妊娠期人群，各种卵巢肿瘤的患病率与一般人群不同，且在这些生命阶段有独特的表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/2b2f34fb6b8b/cancers-15-02106-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/4abfd5bd6fdc/cancers-15-02106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/11de9bd72cf3/cancers-15-02106-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/9f63a50ff7d9/cancers-15-02106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/46a22316204f/cancers-15-02106-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/25bbe3b297e7/cancers-15-02106-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/14ecaf6b71b5/cancers-15-02106-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/d3220e73caf2/cancers-15-02106-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/cfa85352b9ac/cancers-15-02106-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/462173e15eb8/cancers-15-02106-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/b738b07062a1/cancers-15-02106-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/88cd0e81f2ae/cancers-15-02106-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/9e64137fdc20/cancers-15-02106-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/3d0fc74f743a/cancers-15-02106-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/75ad7211c723/cancers-15-02106-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/441114477e6c/cancers-15-02106-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/89888e796cba/cancers-15-02106-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/5ef16fbdb8a8/cancers-15-02106-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/9ab5a843f758/cancers-15-02106-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/c5a078eb48ce/cancers-15-02106-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/3b56345c7485/cancers-15-02106-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/41c733ea64c4/cancers-15-02106-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/4a5c8077a24a/cancers-15-02106-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/2b2f34fb6b8b/cancers-15-02106-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/4abfd5bd6fdc/cancers-15-02106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/11de9bd72cf3/cancers-15-02106-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/9f63a50ff7d9/cancers-15-02106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/46a22316204f/cancers-15-02106-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/25bbe3b297e7/cancers-15-02106-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/14ecaf6b71b5/cancers-15-02106-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/d3220e73caf2/cancers-15-02106-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/cfa85352b9ac/cancers-15-02106-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/462173e15eb8/cancers-15-02106-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/b738b07062a1/cancers-15-02106-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/88cd0e81f2ae/cancers-15-02106-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/9e64137fdc20/cancers-15-02106-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/3d0fc74f743a/cancers-15-02106-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/75ad7211c723/cancers-15-02106-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/441114477e6c/cancers-15-02106-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/89888e796cba/cancers-15-02106-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/5ef16fbdb8a8/cancers-15-02106-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/9ab5a843f758/cancers-15-02106-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/c5a078eb48ce/cancers-15-02106-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/3b56345c7485/cancers-15-02106-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/41c733ea64c4/cancers-15-02106-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/4a5c8077a24a/cancers-15-02106-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb4/10093428/2b2f34fb6b8b/cancers-15-02106-g023.jpg

相似文献

1
Manifestations of Ovarian Cancer in Relation to Other Pelvic Diseases by MRI.MRI 显示的卵巢癌与其他盆腔疾病的关系
Cancers (Basel). 2023 Mar 31;15(7):2106. doi: 10.3390/cancers15072106.
2
Benign and Suspicious Ovarian Masses-MR Imaging Criteria for Characterization: Pictorial Review.良性和疑似卵巢肿块的 MRI 特征：影像学综述。
J Oncol. 2012;2012:481806. doi: 10.1155/2012/481806. Epub 2012 Mar 22.
3
MR imaging of ovarian masses: classification and differential diagnosis.卵巢肿块的磁共振成像：分类与鉴别诊断
Insights Imaging. 2016 Feb;7(1):21-41. doi: 10.1007/s13244-015-0455-4. Epub 2015 Dec 16.
4
Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.交界性卵巢肿瘤：法国 CNGOF 指南。第 1 部分。流行病学、生物病理学、影像学和生物标志物。
J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101965. doi: 10.1016/j.jogoh.2020.101965. Epub 2020 Nov 4.
5
Complex US adnexal masses during pregnancy: Is pelvic MR imaging accurate for characterization?孕期复杂的附件包块：盆腔磁共振成像对其特征描述准确吗？
Eur J Radiol. 2017 Aug;93:200-208. doi: 10.1016/j.ejrad.2017.05.024. Epub 2017 May 22.
6
Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.基于增强非动态对比增强磁共振成像（MRI）的O-RADS MRI风险分层系统在附件包块评估中的准确性和可重复性
Eur J Radiol. 2023 Feb;159:110670. doi: 10.1016/j.ejrad.2022.110670. Epub 2022 Dec 24.
7
Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.卵巢-附件报告数据系统磁共振成像（O-RADS MRI）评分用于超声不确定附件肿块的风险分层。
JAMA Netw Open. 2020 Jan 3;3(1):e1919896. doi: 10.1001/jamanetworkopen.2019.19896.
8
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.HE4 在亚洲盆腔肿块女性卵巢癌预测中的应用。
Gynecol Oncol. 2013 Feb;128(2):239-44. doi: 10.1016/j.ygyno.2012.09.034. Epub 2012 Oct 10.
9
Magnetic Resonance Imaging Findings in Patients with Benign and Malignant Ovarian Masses Versus Pathologic Outcomes.良性和恶性卵巢肿块患者的磁共振成像结果与病理结果对比
Adv Biomed Res. 2020 Oct 30;9:64. doi: 10.4103/abr.abr_253_19. eCollection 2020.
10
A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.一项前瞻性研究评估了可疑卵巢肿块患者的恶性肿瘤风险指数及其诊断意义。
J Ovarian Res. 2017 Aug 14;10(1):55. doi: 10.1186/s13048-017-0351-2.

引用本文的文献

1
Imaging Evaluation of Ovarian Masses in a Pediatric Population: A Comprehensive Overview.儿科人群卵巢肿块的影像学评估：全面概述
Cancers (Basel). 2025 Jul 11;17(14):2316. doi: 10.3390/cancers17142316.
2
Review of the Imaging Modalities in the Gynecological Neoplasms During Pregnancy.孕期妇科肿瘤的影像学检查方法综述
Cancers (Basel). 2025 Feb 28;17(5):838. doi: 10.3390/cancers17050838.
3
Early Diagnosis of Ovarian Cancer: A Comprehensive Review of the Advances, Challenges, and Future Directions.卵巢癌的早期诊断：进展、挑战及未来方向综述

本文引用的文献

1
MRI Improves the Characterization of Incidental Adnexal Masses Detected at Sonography.磁共振成像可改善超声检查发现的附件区意外肿块的特征描述。
Radiology. 2023 Apr;307(1):e222866. doi: 10.1148/radiol.222866. Epub 2022 Nov 22.
2
Adnexal masses during pregnancy: diagnosis, treatment, and prognosis.妊娠附件包块：诊断、治疗和预后。
Am J Obstet Gynecol. 2023 Jun;228(6):601-612. doi: 10.1016/j.ajog.2022.11.1291. Epub 2022 Nov 19.
3
Utility of the Diffusion Weighted Sequence in Gynecological Imaging: Review Article.扩散加权序列在妇科成像中的应用：综述文章。
Diagnostics (Basel). 2025 Feb 7;15(4):406. doi: 10.3390/diagnostics15040406.
4
Diagnostic Challenges and Treatment Options for Mucocle of the Appendix: A Comprehensive Review.阑尾黏液囊肿的诊断挑战与治疗选择：综述
Cureus. 2024 Aug 4;16(8):e66142. doi: 10.7759/cureus.66142. eCollection 2024 Aug.
5
Ovarian steroid cell tumors, not otherwise specified: three case reports and literature review.未另行指定的卵巢类固醇细胞瘤：三例病例报告及文献综述
Front Oncol. 2024 Jul 4;14:1400085. doi: 10.3389/fonc.2024.1400085. eCollection 2024.
6
Prediction of Chemotherapy Efficacy in Patients with Colorectal Cancer Ovarian Metastases: A Preliminary Study Using Contrast-Enhanced Computed-Tomography-Based Radiomics.结直肠癌卵巢转移患者化疗疗效的预测：一项基于对比增强计算机断层扫描的影像组学初步研究
Diagnostics (Basel). 2023 Dec 19;14(1):6. doi: 10.3390/diagnostics14010006.
7
Value of ultrasound and magnetic resonance imaging combined with tumor markers in the diagnosis of ovarian tumors.超声及磁共振成像联合肿瘤标志物在卵巢肿瘤诊断中的价值
World J Clin Cases. 2023 Nov 6;11(31):7553-7561. doi: 10.12998/wjcc.v11.i31.7553.
Cancers (Basel). 2022 Sep 15;14(18):4468. doi: 10.3390/cancers14184468.
4
Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study.全球卵巢癌负担、风险因素及时间趋势：一项全球研究。
Cancers (Basel). 2022 Apr 29;14(9):2230. doi: 10.3390/cancers14092230.
5
Decidualized ovarian endometrioma mimicking malignancy in pregnancy: a case report and literature review.妊娠蜕膜化卵巢子宫内膜异位囊肿酷似恶性肿瘤：病例报告及文献复习。
J Ovarian Res. 2022 Mar 9;15(1):33. doi: 10.1186/s13048-022-00966-6.
6
Diagnostic, Prognostic and Predictive Markers in Pediatric Germ Cell Tumors-Past, Present and Future.小儿生殖细胞肿瘤的诊断、预后和预测标志物——过去、现在与未来
Diagnostics (Basel). 2022 Jan 21;12(2):278. doi: 10.3390/diagnostics12020278.
7
Pearls and Potential Pitfalls for Correct Diagnosis of Ovarian Cystadenofibroma in MRI: A Pictorial Essay.MRI 正确诊断卵巢囊腺纤维瘤的要点及潜在陷阱：影像学分析。
Korean J Radiol. 2021 Nov;22(11):1809-1821. doi: 10.3348/kjr.2020.1312. Epub 2021 Sep 24.
8
ADNEX Model-Based Diagnosis of Ovarian Cancer Using MRI Images.基于 ADNEX 模型的 MRI 图像卵巢癌诊断
Contrast Media Mol Imaging. 2021 Aug 18;2021:2146578. doi: 10.1155/2021/2146578. eCollection 2021.
9
Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice Guidelines.欧洲肿瘤内科学会（ESMO）临床实践指南中关于新诊断上皮性卵巢癌的更新治疗建议。
Ann Oncol. 2021 Oct;32(10):1300-1303. doi: 10.1016/j.annonc.2021.07.004. Epub 2021 Jul 21.
10
Imaging during pregnancy: What the radiologist needs to know.妊娠期影像学检查：放射科医师须知
Diagn Interv Imaging. 2021 Oct;102(10):593-603. doi: 10.1016/j.diii.2021.05.003. Epub 2021 May 28.